OTOF Gene Therapy: 2.5-Year Success in Hearing Restoration
The medical community is witnessing a paradigm shift in the treatment of congenital deafness, moving from the lifelong reliance on prosthetic hardware to the biological restoration of hearing. Recent clinical breakthroughs in AAV-mediated gene therapy for DFNB9—a specific form of nonsyndromic deafness—suggest that we are entering an era of “precision otology,” where the underlying genetic … Read more